industry-sponsored symposium

 

• TUESDAY 16 NOVEMBER
• THURSDAY 18 NOVEMBER

• 16.30-17.30h	Management of Poor Responders: Exploring Therapeutic Considerations Chairman: Dr. Gaurang Daftary Global Scientific Vice President, RMMH, Ferring Pharmaceuticals  The Poor Responder: Evolving our understanding Dr. Christine Wyns Head of the Cliniques Universitaires Saint-Luc's Gynaecology and Andrology Department Medical Director of the Reproductive Tissue and Cell Bank. Professor at Université Catholique de Louvain.  The Poor Responder: Protocol considerations Dr. Juan Antonio García Velasco Director of IVI Madrid. Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid, Spain.  The Poor Responder: Clinical Practice Drs. Wyns & García Velasco CHECH THE PROGRAM
  17.30-18.30h	The era of individual luteal phase support (iLPS) has begun Chairman: Joaquín Llácer Medical Director Ginefiv-GeneraLife Spain Importance of progesterone levels during implantation Dominique De Ziegler University Consultant at Foch Hospital, France Beyond implantation. Progesterone levels for maintenance of pregancy Elena Labarta Gynaecologist specialized in assisted reproduction. IVIRMA, Spain CHECH THE PROGRAM
  18.30-19.30h	Personalized Management of patients in reproductive medicine Moderator: Monica Lispi GMA Merck  Speaking about success in Normoresponders Dr. Filippo Ubaldi  Who may benefit of rLH? Dr. Shahar Kol CHECH THE PROGRAM

• 16.30-17.30h	How Artificial Intelligence could improve IVF utilizationWelcome Chairman: Nick Macklon  Overview of artificial Intelligence in Healthcare Ignacio H. Medrano Founder & Chief Medical Officer at SAVANA  Clinical integration into IVF of Artificial Intelligence and Machine learning Ernesto Bosch Medical Director IVIRMA Valencia  Conclusions Chairman Nick Macklon CHECH THE PROGRAM
  17.30-18.30h	Organon Introduction (10’) Keith Gordon Executive Global Director of Fertility Medical affairs in Organon (Chairman)  Customizing the approach of ovarian stimulation for every patient category Christophe Blockeel Medical Director Centre for Reproductive Medicine, UZ Brussel  Q&A (10’-15’) CHECH THE PROGRAM
  18.30-19.30h	Why an electronic witnessing system is valued as an essential team player by both clinics and patients Moderator: Karen Schnauffer  The Lab Managers perspective on why RI Witness should be considered a “team player” in the lab Albert Obradors Founder and Lab Director FIV Obradors The patient perspective on the benefits of an electronic witnessing system Stephen Troup Consultant Reproductive Scientist CHECH THE PROGRAM